| Yang, GuoPing |
NCT05630573: A Study of TNM001 in Chinese Healthy Preterm and Term Infants |
|
|
| Completed | 1/2 | 31 | RoW | TNM001, Placebo | Zhuhai Trinomab Pharmaceutical Co., Ltd. | Respiratory Syncytial Virus Infections | 06/23 | 06/23 | | |
NCT06350812: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects |
|
|
| Active, not recruiting | 1/2 | 32 | RoW | PB-119, Placebo | PegBio Co., Ltd. | Obesity | 04/25 | 04/25 | | |
NCT04973722: A Study to Evaluate LY06006 and Prolia in Healthy Adults |
|
|
| Active, not recruiting | 1 | 168 | RoW | LY06006, subcutaneous injection of 60 mg, Prolia, Denosumab | Luye Pharma Group Ltd., Shan Dong Boan Biotechnology Co., Ltd | Healthy Adults | 04/21 | 12/21 | | |
NCT05701826: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS3797 in Healthy Subjects |
|
|
| Completed | 1 | 35 | RoW | HRS3797 | Fujian Shengdi Pharmaceutical Co., Ltd. | Skeletal Muscle Relaxation | 06/23 | 06/23 | | |
NCT05932888: Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects |
|
|
| Completed | 1 | 40 | RoW | QLM3003, QLM3003 Placebo | Qilu Pharmaceutical Co., Ltd. | Atopic Dermatitis | 08/23 | 08/23 | | |
| Terminated | 1 | 12 | RoW | SHR-1210 | Jiangsu HengRui Medicine Co., Ltd. | Advanced Tumors | 10/23 | 10/23 | | |
NCT06547775: A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight |
|
|
| Recruiting | 1 | 36 | RoW | KN069 | Suzhou Alphamab Co., Ltd. | Overweight or Obesity | 04/25 | 06/25 | | |
NCT05776121: Study of ZB001 in Chinese Patients With Thyroid Eye Disease |
|
|
| Active, not recruiting | 1 | 17 | RoW | ZB001 for injection | Zenas BioPharma (USA), LLC | Thyroid Eye Disease | 10/24 | 10/24 | | |
NCT06619392: A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects |
|
|
| Recruiting | 1 | 44 | RoW | HRS-2129, HRS-2129 Placebo | Shandong Suncadia Medicine Co., Ltd. | Pain | 01/25 | 01/25 | | |
NCT06742840: A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects |
|
|
| Not yet recruiting | 1 | 50 | RoW | HRS-2129, HRS-2129 placebo | Shandong Suncadia Medicine Co., Ltd. | Pain | 07/26 | 07/26 | | |
